Black Friday saleUp to 70% OFF
000

MYUNGMOON PHARM

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

017180 chart


Full chart

Key stats


Market capitalization
‪64.37 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−226 KRW
Net income (FY)
‪−4.52 B‬ KRW
Revenue (FY)
‪169.57 B‬ KRW
Shares float
‪25.78 M‬
Beta (1Y)
0.38

Employees


Employees (FY)
291
Change (1Y)
−6 −2.02%
Revenue / Employee (1Y)
‪447.52 K‬ KRW
Net income / Employee (1Y)
‪−11.94 K‬ KRW

About MYUNGMOON PHARM


Sector
Health Technology
CEO
Choon-Sik Park
Headquarters
Hwaseong-si
Website
mmpharm.co.kr
Founded
1983
ISIN
KR7017180001
FIGI
BBG000BK7P09
MYUNGMOON Pharm Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include ethical drugs (ETC), over-the-counter drugs (OTC), and indication drugs. The ethical drugs include anesthetic agent, analgesic agent, anti-epileptics, anti-depressants, anti-diabetics, anti-osteoporosis, and others. The over-the-counter drugs provide medicines for eye nutrition, colds, parasiticide, cathartic, muscle relaxant, hepatics, and others. The company was founded on September 1, 1983 and is headquartered in Hwaseong, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 017180 is 1,872 KRW — it has decreased by −1.68% in the past 24 hours. Watch MYUNGMOON PHARM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MYUNGMOON PHARM stocks are traded under the ticker 017180.
017180 stock has fallen by −2.25% compared to the previous week, the month change is a −18.79% fall, over the last year MYUNGMOON PHARM has showed a −15.87% decrease.
017180 reached its all-time high on Dec 22, 2020 with the price of 11,750 KRW, and its all-time low was 1,291 KRW and was reached on Oct 28, 2008. View more price dynamics on 017180 chart.
See other stocks reaching their highest and lowest prices.
017180 stock is 4.61% volatile and has beta coefficient of 0.38. Track MYUNGMOON PHARM stock price on the chart and check out the list of the most volatile stocks — is MYUNGMOON PHARM there?
Today MYUNGMOON PHARM has the market capitalization of ‪63.65 B‬, it has increased by 0.85% over the last week.
Yes, you can track MYUNGMOON PHARM financials in yearly and quarterly reports right on TradingView.
017180 net income for the last quarter is ‪−794.23 M‬ KRW, while the quarter before that showed ‪−1.53 B‬ KRW of net income which accounts for 48.24% change. Track more MYUNGMOON PHARM financial stats to get the full picture.
As of Nov 29, 2024, the company has 291.00 employees. See our rating of the largest employees — is MYUNGMOON PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MYUNGMOON PHARM EBITDA is ‪524.25 M‬ KRW, and current EBITDA margin is 2.67%. See more stats in MYUNGMOON PHARM financial statements.
Like other stocks, 017180 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYUNGMOON PHARM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYUNGMOON PHARM technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYUNGMOON PHARM stock shows the strong sell signal. See more of MYUNGMOON PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.